Accelerant ARX Q3 2026: Revenue Beat, Earnings Miss, Underwriting Swings to a Loss
As seen on the 24/7 Wall St. homepage on November 12, 2026.
Underwriting swung to a $13.2 million adjusted EBITDA loss from a $17.2 million profit a year ago as the gross loss ratio widened to 56.8%, which is why revenue topped estimates while earnings missed expectations. With the Thoma Bravo take-private pending into the first half of 2027, there was no earnings call and no guidance to cushion it.
Continue ReadingShow less
Accelerant reported Q3 2026 revenue of $278.6 million, clearing the $265.4 million consensus by about 5%. On the bottom line, however, adjusted EPS of $0.18 missed the $0.1963 analyst estimate by 8.3%, reflecting deterioration in the company's underwriting book rather than any weakness in its fee-generating businesses.
The sharpest signal in the quarter was the Underwriting segment, which swung from a $17.2 million adjusted EBITDA profit a year ago to a $13.2 million loss. That reversal traces directly to the gross loss ratio widening to 56.8% from 50.1% in the year-earlier period, meaning claims and losses consumed a meaningfully larger share of earned premiums. Net earned premiums did rise to $113.9 million from $82.1 million, but that growth was not enough to offset the deteriorating loss experience.
The fee-based side of the business told a very different story. Exchange Services adjusted EBITDA rose to $73.8 million from $59.2 million, and MGA Operations adjusted EBITDA climbed to $41.0 million from $14.7 million. Exchange Written Premium grew 27% year-over-year to $1.33 billion, and Accelerant added 26 MGAs in the quarter, bringing total membership to 340 from 265 a year earlier. Those figures helped consolidated adjusted EBITDA reach $71.3 million for the period.
Sponsored
CEO Jeff Radke struck an upbeat tone on the exchange platform, noting that third-party direct written premium rose to 49% of exchange volume from 32%, and describing sustained momentum in onboarding high-quality specialty underwriting talent. His headline comment on the strategic picture was straightforward: the company remains excited about the pending Thoma Bravo transaction and continues to expect a first-half 2027 close.
Because that take-private deal remains pending, Accelerant did not host an earnings call and provided no guidance for Q4 2026 or the full year. Investors have no management commentary to contextualize the underwriting losses or the compressed adjusted EBITDA margin of 25%, down from 29% a year ago, and no forward outlook to anchor expectations until the deal closes or circumstances change.
Mentioned: ARX